Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01100619
What this trial is testing

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

Who this might be right for
Papillary Thyroid CancerFollicular Thyroid CancerHuerthle Cell Thyroid Cancer+1 more
Exelixis 40
Very early researchUnknownNCT06532630
What this trial is testing

Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies

Who this might be right for
B-Cell Malignancy
Shanghai First Song Biotechnology Co., LTD 9
Early research (Phase 1)Study completedNCT00440128
What this trial is testing

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT00002828
What this trial is testing

Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT04833582
What this trial is testing

Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma

Who this might be right for
Osteosarcoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 31
Early research (Phase 1)Ended earlyNCT03915405
What this trial is testing

KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer

Who this might be right for
Urothelial Carcinoma
Kyowa Kirin, Inc. 16
Not applicableActive Not RecruitingNCT03941379
What this trial is testing

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Who this might be right for
Choroidal MelanomaIndeterminate Lesions of Eye
Aura Biosciences 63
Testing effectiveness (Phase 2)Looking for participantsNCT07008703
What this trial is testing

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

Who this might be right for
Cancer Pain
Shenyang Sunshine Pharmaceutical Co., LTD. 132
Large-scale testing (Phase 3)Looking for participantsNCT07015190
What this trial is testing

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 520
Testing effectiveness (Phase 2)Study completedNCT05975073
What this trial is testing

Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Who this might be right for
MTAP-null Non-Small-Cell Lung CancerMTAP-null Solid Tumors
Amgen 53
Testing effectiveness (Phase 2)Study completedNCT00364780
What this trial is testing

Study of XL647 in Subjects With Non-Small-Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Kadmon Corporation, LLC 55
Testing effectiveness (Phase 2)Study completedNCT00982488
What this trial is testing

Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Bristol-Myers Squibb 238
Early research (Phase 1)Study completedNCT05147727
What this trial is testing

Drug-drug Interaction Study Between Fluconazole and Famitinib in Healthy Subjects

Who this might be right for
Tumor
Jiangsu HengRui Medicine Co., Ltd. 22
Early research (Phase 1)Study completedNCT01732861
What this trial is testing

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Who this might be right for
Leukemia Lymphocytic Chronic B-Cell
Celgene 20
Early research (Phase 1)UnknownNCT04758897
What this trial is testing

Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
CNBG-Virogin Biotech (Shanghai) Ltd. 18
Early research (Phase 1)Ended earlyNCT03296696
What this trial is testing

Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma

Who this might be right for
Glioblastoma or Malignant Glioma
Amgen 30
Early research (Phase 1)Study completedNCT03941262
What this trial is testing

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

Who this might be right for
Refractory CancerMetastatic CancerRecurrent Cancer+4 more
NKGen Biotech, Inc. 27
Testing effectiveness (Phase 2)Ended earlyNCT02495103
What this trial is testing

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaHereditary LeiomyomatosisRenal Cell Cancer
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT00479583
What this trial is testing

Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX

Who this might be right for
Cancer
Bristol-Myers Squibb 25
Early research (Phase 1)Active Not RecruitingNCT06980454
What this trial is testing

Phase I PK Comparison of HLX05 vs. Erbitux® in Healthy Chinese Males: Safety, Immunogenicity, and Pharmacokinetics

Who this might be right for
CancermCRC
Shanghai Henlius Biotech 322
Next Page